NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: The Scott Partnership
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

The Scott Partnership Selected by Quotient Bioresearch to Lead Global PR Campaign - The Scott Partnership today announced that it has been appointed by Quotient Bioresearch, a leading provider of early stage and specialist drug development services, to lead the company’s global PR campaign
The Scott Partnership Selected by Quotient Bioresearch to Lead Global PR Campaign

 

NewswireToday - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2010/07/08 - The Scott Partnership today announced that it has been appointed by Quotient Bioresearch, a leading provider of early stage and specialist drug development services, to lead the company’s global PR campaign.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

B2B PR agency The Scott Partnership today announced that it has been appointed by Quotient Bioresearch, a leading provider of early stage and specialist drug development services, to lead the company’s global PR campaign. Following a multi-way pitch, The Scott Partnership, headquartered in Cheshire, UK, was appointed as a result of the agency’s strong track record of delivering expert communications strategies aligned with business objectives to companies in the life sciences industry.

Founded in 2007, Quotient Bioresearch (quotientbioresearch.com) has grown rapidly through a combination of both acquisition-led and organic growth, completing a total of seven acquisitions in just three years of operation. Underpinned by a unique combination of clinical, chemical and biological capabilities, Quotient Bioresearch continually strives to deliver the highest quality of early stage and specialist drug development services in support of its pharmaceutical client base. The company’s extensive range of capabilities span Chemistry and Metabolism, Bioanalytical Sciences and Clinical Services provided independently or integrated into tailored work programmes. Quotient Bioresearch serves a broad scope of customers ranging from global pharmaceutical and clinical companies through to small virtual biotechnology organisations based in the US, Europe and Japan.

During the pitch process Quotient Bioresearch was impressed by The Scott Partnership’s multinational reach and its emphasis on demonstrating return on investment. The agency’s ethos and reputation for delivering effective, results-focused PR campaigns to a number of global organisations in the clinical, biotechnology and pharmaceutical sectors also played a vital role in the decision. Combining strong marketing, communications and public relations knowledge and experience, the agency’s expert team will be planning and managing a global PR campaign for Quotient Bioresearch that will increase awareness and visibility of the company and its breakthrough services.

Nicola Booton-Mander, Group Marketing Communications Manager of Quotient Bioresearch, comments: “The Scott Partnership has been selected over competitive agencies because of the team’s in-depth understanding of technical subjects, ability to deliver a quick turnaround of tangible results and multiple geographic locations. We are delighted to be working with the team to strengthen the brand, reinforce the benefits of our combined service offering and to communicate Quotient Bioresearch as the leading provider of early stage and specialist drug development services.”

The Scott Partnership, headquartered near Manchester, UK, was set up in 1996 as a specialist business-to-business PR consultancy for the scientific and technology industries. The company has expanded year-on-year and is committed to building strong and lasting relationships with both its clients and the media. The addition of Quotient Bioresearch to The Scott Partnership’s client portfolio is the latest in a series of new account appointments over the last three months.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


The Scott Partnership Selected by Quotient Bioresearch to Lead Global PR Campaign

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Scottpr.com 
+44(0)14 7753 9539 pr[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)